236 related articles for article (PubMed ID: 10571691)
1. Skeletal dysplasia and defective chondrocyte differentiation by targeted overexpression of fibroblast growth factor 9 in transgenic mice.
Garofalo S; Kliger-Spatz M; Cooke JL; Wolstin O; Lunstrum GP; Moshkovitz SM; Horton WA; Yayon A
J Bone Miner Res; 1999 Nov; 14(11):1909-15. PubMed ID: 10571691
[TBL] [Abstract][Full Text] [Related]
2. A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model.
Jonquoy A; Mugniery E; Benoist-Lasselin C; Kaci N; Le Corre L; Barbault F; Girard AL; Le Merrer Y; Busca P; Schibler L; Munnich A; Legeai-Mallet L
Hum Mol Genet; 2012 Feb; 21(4):841-51. PubMed ID: 22072392
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype.
Murakami S; Balmes G; McKinney S; Zhang Z; Givol D; de Crombrugghe B
Genes Dev; 2004 Feb; 18(3):290-305. PubMed ID: 14871928
[TBL] [Abstract][Full Text] [Related]
4. FGF upregulates osteopontin in epiphyseal growth plate chondrocytes: implications for endochondral ossification.
Weizmann S; Tong A; Reich A; Genina O; Yayon A; Monsonego-Ornan E
Matrix Biol; 2005 Dec; 24(8):520-9. PubMed ID: 16253490
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway.
Yasoda A; Komatsu Y; Chusho H; Miyazawa T; Ozasa A; Miura M; Kurihara T; Rogi T; Tanaka S; Suda M; Tamura N; Ogawa Y; Nakao K
Nat Med; 2004 Jan; 10(1):80-6. PubMed ID: 14702637
[TBL] [Abstract][Full Text] [Related]
6. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.
Colvin JS; Bohne BA; Harding GW; McEwen DG; Ornitz DM
Nat Genet; 1996 Apr; 12(4):390-7. PubMed ID: 8630492
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias.
Legeai-Mallet L; Benoist-Lasselin C; Munnich A; Bonaventure J
Bone; 2004 Jan; 34(1):26-36. PubMed ID: 14751560
[TBL] [Abstract][Full Text] [Related]
8. Expression of fibroblast growth factor receptor 3 by fibroblast growth factor 2 in cultured chick embryo chondrocytes.
Suh JY; Kim YS; Park JW; Sonn JK; Kim WT
Cell Biol Int; 2005 Mar; 29(3):203-12. PubMed ID: 15878293
[TBL] [Abstract][Full Text] [Related]
9. Delayed bone age due to a dual effect of FGFR3 mutation in Achondroplasia.
Pannier S; Mugniery E; Jonquoy A; Benoist-Lasselin C; Odent T; Jais JP; Munnich A; Legeai-Mallet L
Bone; 2010 Nov; 47(5):905-15. PubMed ID: 20673820
[TBL] [Abstract][Full Text] [Related]
10. The biological action of parathyroid hormone-related peptide (PTHrP) and fibroblast growth factor receptor 3 (FGFR3) on bone and cartilage.
Amizuka N; Ozawa H; Sasaki T
Kaibogaku Zasshi; 2000 Oct; 75(5):415-25. PubMed ID: 11155687
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of fibroblast growth factor (FGF) 9 and FGF2 on proliferation, differentiation and terminal differentiation of chondrocytic cells in vitro.
Weksler NB; Lunstrum GP; Reid ES; Horton WA
Biochem J; 1999 Sep; 342 Pt 3(Pt 3):677-82. PubMed ID: 10477279
[TBL] [Abstract][Full Text] [Related]
12. Expression and possible function of fibroblast growth factor 9 (FGF9) and its cognate receptors FGFR2 and FGFR3 in postnatal and adult retina.
Cinaroglu A; Ozmen Y; Ozdemir A; Ozcan F; Ergorul C; Cayirlioglu P; Hicks D; Bugra K
J Neurosci Res; 2005 Feb; 79(3):329-39. PubMed ID: 15614790
[TBL] [Abstract][Full Text] [Related]
13. Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3.
Naski MC; Colvin JS; Coffin JD; Ornitz DM
Development; 1998 Dec; 125(24):4977-88. PubMed ID: 9811582
[TBL] [Abstract][Full Text] [Related]
14. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.
Naski MC; Wang Q; Xu J; Ornitz DM
Nat Genet; 1996 Jun; 13(2):233-7. PubMed ID: 8640234
[TBL] [Abstract][Full Text] [Related]
15. Disruption of a Sox9-β-catenin circuit by mutant Fgfr3 in thanatophoric dysplasia type II.
Shung CY; Ota S; Zhou ZQ; Keene DR; Hurlin PJ
Hum Mol Genet; 2012 Nov; 21(21):4628-44. PubMed ID: 22843502
[TBL] [Abstract][Full Text] [Related]
16. An activating Fgfr3 mutation affects trabecular bone formation via a paracrine mechanism during growth.
Mugniery E; Dacquin R; Marty C; Benoist-Lasselin C; de Vernejoul MC; Jurdic P; Munnich A; Geoffroy V; Legeai-Mallet L
Hum Mol Genet; 2012 Jun; 21(11):2503-13. PubMed ID: 22367969
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains.
Wang Q; Green RP; Zhao G; Ornitz DM
Development; 2001 Oct; 128(19):3867-76. PubMed ID: 11585811
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-1 rescues the mutated FGF receptor 3 (G380R) expressing ATDC5 cells from apoptosis through phosphatidylinositol 3-kinase and MAPK.
Koike M; Yamanaka Y; Inoue M; Tanaka H; Nishimura R; Seino Y
J Bone Miner Res; 2003 Nov; 18(11):2043-51. PubMed ID: 14606518
[TBL] [Abstract][Full Text] [Related]
19. Perlecan is essential for cartilage and cephalic development.
Arikawa-Hirasawa E; Watanabe H; Takami H; Hassell JR; Yamada Y
Nat Genet; 1999 Nov; 23(3):354-8. PubMed ID: 10545953
[TBL] [Abstract][Full Text] [Related]
20. PTHrP rescues ATDC5 cells from apoptosis induced by FGF receptor 3 mutation.
Yamanaka Y; Tanaka H; Koike M; Nishimura R; Seino Y
J Bone Miner Res; 2003 Aug; 18(8):1395-403. PubMed ID: 12929929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
